Point72 Asset Management, L.P. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$3,035,895
-56.1%
3,097,852
-37.7%
0.01%
-57.1%
Q2 2023$6,915,250
+20.8%
4,975,000
+38.2%
0.02%
+16.7%
Q1 2023$5,724,000
-62.1%
3,600,000
+48.3%
0.02%
-64.7%
Q4 2022$15,120,210
-20.5%
2,427,000
-14.5%
0.05%
-32.9%
Q3 2022$19,017,000
+181.3%
2,838,300
+167.0%
0.08%
+162.1%
Q2 2022$6,761,000
-62.8%
1,063,096
+64.0%
0.03%
-65.9%
Q1 2021$18,182,000
+6257.3%
648,200
+13404.2%
0.08%
+4150.0%
Q4 2019$286,000
-98.1%
4,800
-98.9%
0.00%
-97.9%
Q3 2019$15,375,000
+395.0%
419,390
+528.1%
0.09%
+487.5%
Q2 2019$3,106,000
-64.4%
66,773
-69.2%
0.02%
-60.0%
Q1 2019$8,717,000
-61.3%
217,100
-57.2%
0.04%
-57.0%
Q3 2018$22,509,000
+57.7%
507,300
+39.3%
0.09%
+63.2%
Q2 2018$14,269,000
+685.7%
364,100
+372.9%
0.06%
+307.1%
Q3 2015$1,816,000
-42.7%
77,000
+98.5%
0.01%
-36.4%
Q2 2015$3,172,000
+632.6%
38,800
+262.6%
0.02%
+633.3%
Q4 2014$433,00010,7000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$99,609,00022.32%
Bellevue Group AG 5,465,715$203,160,0002.81%
Rhenman & Partners Asset Management AB 455,000$16,912,0001.50%
Endurant Capital Management LP 135,901$5,051,0001.49%
Boxer Capital, LLC 975,000$36,241,0001.25%
DCF Advisers, LLC 56,500$2,100,0001.07%
Pentwater Capital Management LP 2,169,022$80,623,0001.04%
Nicholas Investment Partners, LP 235,855$8,767,0000.95%
Amia Capital LLP 20,464$761,0000.88%
HAMILTON LANE ADVISORS LLC 46,181$1,717,0000.83%
View complete list of ESPERION THERAPEUTICS INC NE shareholders